Labena Slovenia’s Post

💫 Living Labena’s Mission: Driving Innovation, Enabling Discoveries 💫 At Labena, innovation isn’t just a value—it’s our everyday reality. We are incredibly proud to share this inspiring story from Labena Slovenia, where our commitment to advancing science is making a tangible difference. 💙 The development of Urbagen, a gene therapy for the rare CTNNB1 genetic disorder, is a testament to what happens when science meets determination. After years of searching for answers, Urban’s family found hope in Slovenia. It’s an honor for Labena to be part of this journey, providing advanced molecular biology analytics to help bring this groundbreaking treatment to life. 👩🔬 Our Ljubljana Research & Development laboratories stand as a beacon of excellence, supporting global medicine development. From ensuring the quality of viral vectors for Urban’s therapy to advancing treatments for rare diseases worldwide, we remain dedicated to enabling discoveries that transform lives. Let’s continue driving innovation, one breakthrough at a time. 🌟 #LabenaSlovenia #LabenaGroup #Innovation #HealthcareInnovation #SupportingScience Labena Slovenia Labena Hrvatska Labena Srbija Labena Makedonija Labena Ventures

Revolucija pridelka graha: podvojitev produktivnosti pridelka z uporabo biotehnologije Scientists have identified a gene responsible for the duration of the reproductive phase of peas. Biotechnologies using this gene discovery... https://lnkd.in/eEbrQzVc

UGenome People | Husna Rahim Husna Rahim, PharmD serves as UGenome AI’s Manager of Clinical Content. She is passionate about applying scientific research to benefit patients and revolutionize treatment paradigms. With experience in both clinical and commercial healthcare settings, Dr. Rahim uniquely understands the patient perspective as well as business realities. Through her work translating genomic discoveries into practical guidance and empowering more personalized patient care, Husna is advancing the promise of precision medicine at the forefront of pharmacogenomics. Prior to this, she worked in product strategy and brand management for Bayer Pharma's rare disease business unit. #ugenome, #ugenomeai, #ugenomebiotech, #bioinformatics, #biotech, #genetics,

Reference Genes for Expression Analyses by qRT-PCR in Phthorimaea operculella (Lepidoptera: Gelechiidae) 👉Open Access: https://brnw.ch/21wP5r7 #mdpiinsects #Lepidoptera

We are very pleased to share that our review article "Deciphering the Lexicon of Protein Targets: A Review on Multifaceted Drug Discovery in the Era of Artificial Intelligence" is online now on ACS Molecular Pharmaceutics (IF: 4.9). Suvendu Nandi Pralay Mitra #research #CoSMoS #CancerBiologyLab #deeplearning #acs #iitkgp

In our final July webinar in the Emerge #HealthTechTalk series we talk about how to bring complex modeling to the bedside. Sharmeen Roy, PharmD, BCPS of DoseMe will be discussing how through model-informed precision dosing we can improve the outcome of the patients. Wrapping up this discussion, we look to the future with the integration of #pharmacogenomics into #MIPD algorithms. This approach aims to refine and personalize dosing regimens, enhance ongoing research, and explore potential frameworks for incorporating genetic markers into MIPD models, ultimately optimizing drug efficacy and safety. Please join us on Wednesday at 4:30 DXB for this informative talk. Register here: https://lnkd.in/dyi-BsgX #precisiondosing #algorythms #AIHealth #webinar #drugefficacy #drugsafety

Have you ever thought about the potential impact of genomics on drug discovery? 🤔 Will Ferguson, VP of Pharmaceutical & Biotech Collaborations at Illumina, chatted with Automata's Lara Matthews about this very topic. In their call, they discuss the potential impact of large-scale genetic data analysis on finding new therapeutic targets, as well as anticipating breakthroughs in neuroscience and cardiometabolic diseases. Lara will be sharing the session highlights on her profile over the next few weeks, be sure to give her a follow ✅ #BioTech #Genomics #Healthcare

Are you maximizing insights from the genetic data generated in your lab? Allelica's solution for #PRS and #PGx clinical reporting is compatible with genome-wide microarray and WGS technologies, and is available for use in-house - so your data never leaves your lab. For more information on solutions for PRS and PGx, send us a message at [email protected] 

#Pharmacogenomics seeks to understand the interaction between an individual's genetic information and response to medication. However, clinical implementation remains slow despite growing body of evidence recognizing genetic variations to be an important factor. To facilitate uptake, it'll take various stakeholders to come together. Hosted by STRIPE, the Partners in Precision Medicine "How to Find a Laboratory of Excellence" is now available for readers. The series interviewed experts and leaders to share their perspective of the field, unique barriers that they face, and to offer potential ways forward. This initial bundle consists of: Introduction: https://rdcu.be/dXShc Pharmacist Perspective: https://rdcu.be/dXSyy Provider Perspective: https://rdcu.be/dXSyX

Interested in AI applications in molecular diagnostics? Come and listen to my talk tomorrow morning at the Microbiology Society Conference 2024, about my work with Vidiia Ltd! I will be giving a presentation in the "Navigating the Future of Antimicrobial resistance: Innovative strategies in Diagnostic and Surveillance" session. The goal of our collaborative work: To develop and commercialise highly accurate tests requiring minimal equipment and training, empowering healthcare professionals worldwide. #Microbio24 #molecularbiology #diagnostics #Artificialintelligence